Waldencast plc (WALDW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 4

ValuationView details →

P/E (Fwd)

1.9x

EV/EBITDA

−1.0x

Market Cap

$3.09M

MomentumView details →

1D Return

+12.70%

YTD Return

−48.25%

RSI (14)

30.3

ValuationView details →

P/E (Fwd)

1.9x

EV/EBITDA

−1.0x

Market Cap

$3.09M

RSI (14)

30.3

MomentumView details →

1D Return

+12.70%

YTD Return

−48.25%

ProfitabilityView details →

Gross Margin

57.80%

Net Margin

−49.86%

EBITDA Margin

−27.85%

ROE (TTM)

−58.93%

ROA (TTM)

−33.35%

Asset Turnover

0.68x

GrowthView details →

Revenue YoY

+42.07%

EPS YoY

−31.28%

FCF YoY

+76.64%

Revenue CAGR 3Y

+17.87%

EPS CAGR 3Y

—

EBITDA YoY

−7.46%

EarningsView details →

EPS (Actual)

−$0.51

EPS Surprise

—

Beats (12Q)

0/12

Next Q EPS Est

$0.01

Avg Surprise (4Q)

−4296.02%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.32x

Current Ratio

1.70x

Quick Ratio

0.97x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

545.94M

Net Income (TTM)

−272.19M

Op. CF (TTM)

−21.64M

Latest newsMore news →

Waldencast completed the sale of its Obagi Medical business to Bridgepoint for up to $460 million.36d ago

Waldencast Plc filed a lawsuit in Delaware's Chancery Court against former Obagi CEO Jaime Castle and former parent Cedarwalk Skincare Ltd., alleging a channel-stuffing scheme that inflated Obagi's earnings by $50 million and caused Waldencast to overpay by hundreds of millions of dollars.39d ago

Similar companies

HeartCore Enterprises, Inc.HTCR Fold Holdings, Inc. Warrant 2021-14.02.30 on Fold Holding -A-FLDDW AGM Group Holdings Inc.AGMH Webus International Limited Ordinary SharesWETO Banzai International, Inc. Class APARA NetClass Technology IncNTCL Find similar companies →

Latest newsMore news →

Waldencast completed the sale of its Obagi Medical business to Bridgepoint for up to $460 million.36d ago Waldencast Plc filed a lawsuit in Delaware's Chancery Court against former Obagi CEO Jaime Castle and former parent Cedarwalk Skincare Ltd., alleging a channel-stuffing scheme that inflated Obagi's earnings by $50 million and caused Waldencast to overpay by hundreds of millions of dollars.39d ago The FDA approved Obagi saypha ChIQ injectable hyaluronic acid gel for Obagi Medical, a brand of Waldencast plc.81d ago